Vivo Capital, LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 17 filers reported holding SOLENO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$4,811,000
-59.8%
2,021,377
-52.6%
0.44%
-61.1%
Q2 2019$11,953,000
+33.1%
4,268,959
-2.1%
1.12%
+25.0%
Q1 2019$8,981,000
+20.5%
4,359,6830.0%0.90%
-5.9%
Q4 2018$7,455,000
-20.8%
4,359,6830.0%0.95%
+0.3%
Q3 2018$9,417,000
-7.7%
4,359,6830.0%0.95%
-27.8%
Q2 2018$10,202,000
+39.5%
4,359,683
+8.1%
1.32%
+26.9%
Q1 2018$7,313,000
+0.7%
4,033,5340.0%1.04%
-33.4%
Q4 2017$7,260,0004,033,5341.56%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders